N/A
- Pharmaceuticals
- Osmotic Laxative Market
Osmotic Laxative Market
Osmotic Laxative Market - Global Industry Trend Analysis 2015 to 2019 and Forecast 2020 - 2028
Market Overview
Osmotic laxatives are hypertonic agents that holds more water colon and generate an osmotic effect that stimulates a bowel movement and results in softer stools.
Osmotic laxatives are considered as the drug of choice for treatment of constipation. Lactulose, Polyethene glycol (PEG) and milk of magnesia are some commonly used osmotic laxatives. In February 2020, LACTITOL manufactured by Braintree laboratories was approved by USFDA as an osmotic laxative for the treatment of chronic idiopathic constipation (CIC).
The COVID-19 pandemic is unlikely to have a significant impact on the operations of the osmotic laxative industry. Changes in consumer lifestyle during lockdown and diet during quarantines have a positive impact on sales of osmotic laxatives.
Osmotic Laxative Market: Drivers and Restraints
Rising prevalence of constipation in the ageing population is the key factor driving the growth of the osmotic laxative market. Increase in lifestyle changes, lack of exercise and diet-related factors such as eating unhealthy and junk food supplements the osmotic laxative market growth.
The elder population are suffering some problems such as the inability to digest food properly and reduction in muscles elasticity which leads to improper bowel functioning. However, increasing prevalence of bowel diseases in geriatric population leads the osmotic laxative market to grow.
Osmotic laxatives may take 2-3 days to show effect so they are not suitable for the rapid relief of constipation. Moreover, side effects associated with osmotic laxatives and the presence of alternative treatment are anticipated to restrain the osmotic laxative market growth.
Osmotic Laxative Market: Segmentation
The osmotic laxative market can be segmented based on the product type, route of administration, dosage forms, prescription type, distribution channel, and region.
| Based on product type |
|
| Based on the route of administration |
|
| Based on the dosage forms |
|
| Based on prescription type |
|
| Based on the distribution channel |
|
| Based on regions |
|
Osmotic Laxative Market: Overview
Lactulose is well-tolerated and is recommended over other osmotic laxatives in geriatric population, due to this lactulose segment holds a major share in the osmotic laxative market. Polyethylene Glycol segment is expected to grow in the next few years owing to its rapid onset of action.
Based on the route of administration oral segment dominates the osmotic laxative market due to ease of administration, high patient compliance and it also encourages bowel movements to relieve constipation.
Based on dosage form tablets and liquid segment have the highest share in the osmotic laxative market. Based on the type of prescription, prescribed laxative showed significant growth due to the rising prevalence of constipation associated with chronic disease treatment.
Over-the-counter osmotic laxatives also showed excellent growth during the forecast period, as the rate of self-diagnosed constipation cases increases gradually across the forecast period. Based on distribution drug stores are expected to dominate the osmotic laxative market.
Osmotic laxative Market: Regional Outlook
Approximately 63 million people in North America are suffering from chronic constipation and approximately 12% of people suffer from self-diagnosed constipation across the world.
People in the North America and the Asian Pacific region suffer twice as much as their European counterparts. Thus osmotic laxative market widely expanding in North America and the Asian Pacific region.
Osmotic laxative Market: Key Players
Few key players are operating in the Osmotic laxative Market are Abbott Laboratories, Bayer AG, Procter & Gamble Company, GlaxoSmithKline Consumer Healthcare, Purdue Pharma, Sucampo Pharmaceuticals Inc., Salix Pharmaceuticals, Inc., Edusa Pharmaceuticals and Ironwood Pharmaceuticals, Inc., Pharmos Corporation, Lexicon Pharmaceuticals, Tioga Pharmaceuticals, Inc., Alimentary Health Limited, Boehringer Ingelheim Pharmaceuticals Inc. and Sucampo Pharmaceuticals, Inc.
The report covers exhaustive analysis on:
- Osmotic laxative Market Segments
- Osmotic laxative Market Dynamics
- Osmotic laxative Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America ( Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
- Europe (Germany, Italy, UK, Spain, France, Russia, Belgium, Netherlands, Luxemburg, Norway, Denmark, Iceland, Sweden, Poland, Ukraine, Czech Rep, Rest of Europe)
- Asia Pacific Excluding Japan (India, Australia & New Zealand, Greater China, S. Korea, ASEAN Countries, Rest of APEJ)
- Japan
- CIS & Russia
- The Middle East and Africa (GCC, Turkey, Iran, Israel, South Africa, Rest Of MEA)
Report Highlights:
- Detailed overview of parent Osmotic laxative Market
- Changing market dynamics in the industry
- In-depth Osmotic laxative Market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
